Red X iconGreen tick iconYellow tick icon
The University of Otago is launching a new brand. Find out more

Contact Details

Phone
+64 3 479 5647
Email
laura.gumy@otago.ac.nz
Position
Senior Lecturer
Department
Department of Anatomy
Research summary
Imaging; neurobiology

Research

Dr Laura Gumy is Senior Lecturer at the University of Otago. Dr Gumy’s research focuses on intracellular transport processes and cytoskeletal remodelling in neurons. These are fundamental pathways that when impaired can lead to neuronal dysfunction or nerve regeneration deficits. The Gumy lab uses live imaging, biochemical and genetic methods to identify and interrogate molecular interactions with a role in neural repair.

Mayo-Muñoz, D., Smith, L. M., Garcia-Doval, C., Malone, L. M., Harding, K. R., Jackson, S. A., Hampton, H. G., Fagerlund, R. D., Gumy, L. F., & Fineran, P. C. (2022). Type III CRISPR-Cas provides resistance against nucleus-forming jumbo phages via abortive infection. Proceedings of the Genetics Otago (GO) Annual Symposium. Retrieved from https://blogs.otago.ac.nz/go Conference Contribution - Published proceedings: Abstract

Smith, L. M., Mayo-Muñoz, D., García-Doval, C., Malone, L. M., Harding, K., Jackson, S. A., Hampton, H. G., Gumy, L. F., & Fineran, P. C. (2022). CRISPR-Cas targeting of a nucleus-forming jumbo phage induces abortive infection. Proceedings of the Genetics Otago (GO) Annual Symposium. Retrieved from https://blogs.otago.ac.nz/go Conference Contribution - Published proceedings: Abstract

Mayo-Muñoz, D., Smith, L. M., Garcia-Doval, C., Malone, L. M., Harding, K. R., Jackson, S. A., Hampton, H. G., Fagerlund, R. D., Gumy, L. F., & Fineran, P. C. (2022). Type III CRISPR-Cas provides resistance against nucleus-forming jumbo phages via abortive infection. Molecular Cell, 82, 4471-4486.e9. doi: 10.1016/j.molcel.2022.10.028 Journal - Research Article

Gumy, L. F. (2022, August). Visualising transport in neurons. Verbal presentation at the Advances in Microscopy Satellite Meeting: Queenstown Research Week, Queenstown, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Mayo-Muñoz, D., García-Doval, C., Malone, L. M., Smith, L. M., Hampton, H. G., Gumy, L. F., … Fineran, P. C. (2022, August). Type III CRISPR-Cas enables resistance against nucleus-forming jumbo phages. Verbal presentation at the CRISPR Technologies Satellite Meeting: Queenstown Research Week, Queenstown, New Zealand. Conference Contribution - Verbal presentation and other Conference outputs

Back to top